Kitazato

Kitazato Current Assets

The Current Assets of Kitazato (368A.T) as of Nov 17, 2026 is 14.84 B JPY. In the previous year, Current Assets was 13.71 B JPY — a change of 8.20% (higher).

Current Assets

14.84 BJPY

YoY

8.20%

Last updated:

Current Assets of Kitazato is 2025 14.84 B JPY. Current Assets of Kitazato was 2024 13.71 B JPY. It decreases by 8.20% higher compared to the previous year.

The Kitazato Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2023
11.36 B JPY
Jan 1, 2024
13.71 B JPY
Jan 1, 2025
14.84 B JPY
The Kitazato Current Assets history
YEARCurrent AssetsYoY
14.84 BJPY+8.20%
13.71 BJPY+20.66%
11.36 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Current Assets of Kitazato is 14.84 B JPY in 2025.

Current Assets of Kitazato changed from 13.71 B JPY to 14.84 B JPY, representing a 8.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Kitazato since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Kitazato historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Kitazato

All Key Metrics — Kitazato